17

Aug

2016

Prescription Requirements Refresher

Prescription Requirements

During recent audits, we have noticed an increase in missing required prescription information. Here is a quick refresher of what is required on a valid prescription according to the DEA. 

3

Aug

2016

PerformRx REMINDER: reminder that refills of Drug Enforcement Administration (DEA) Schedule II (CII) Drugs are Prohibited

During a review of 2015 and 2016 claims processing of DEA schedule II (CII) prescription drug claims, PerformRx noticed an increase in the number of schedule II (CII) drugs being incorrectly billed as refills at the point of sale (POS). While this may have been due to an error in entering and submitting prescription claim information to PerformRx, efforts need to continually be made to prevent these types of errors as they can signal potential fraud, waste or abuse incorrectly. Pursuant to 21 U.S.C. ยง 829(a), refills of medications with a DEA schedule II (CII) designation are prohibited at POS.

29

Jul

2016

Pseudoephedrine Training Materials

Pseudoephedrine

APNS and CAPS is proud to announce that it now has the Pseudoephedrine annual training PowerPoint available on the APCI website.

24

Sep

2014

Hydrocodone notice poster for patients

With the upcoming reclassification of hydrocodone combination products (HCPs) into Schedule II on Oct. 6, 2014, your patients may have questions or concerns about obtaining and refilling their prescriptions.

22

Sep

2014

NCPA offers resources on hydrocodone rescheduling

With the DEA's final rule on rescheduling hydrocodone combination products (HCPs) taking effect in less than three weeks, NCPA is making resources about the change available to pharmacists.